Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
This claim is based on the results of clinical trials that evaluated the effects of the weight loss medications offered through the Ro Body Program, including Zepbound (tirzepatide) and Wegovy (semaglutide)
Less frequent dosing means less frequent GI stimulation, which can help with constipation , nausea, and bloating that some patients experience throughout treatment
In May, Ro launched the GLP-1 Supply Tracker to give patients insights on where there are GLP-1 drug shortages and help them find supply with real-time, localized alerts
Track your progress : Use photos, waist measurements, how your clothes fit, and your performance (longer plank holds, deeper squats, less rest) as key markersnot just the scale
Medicares current policy, which excludes anti-obesity medications unless prescribed for another condition like diabetes, exacerbates this issue 2
Retrieved from Keen Insider
